When discussing clinical evidence with your doctor, mention that semaglutide has shown benefits not just for weight loss but also for cardiovascular outcomes in people with existing heart disease
In a trial of semaglutide injection (Wegovy) in patients with T2DM and BMI of 27 kg/m2 or more, diabetic retinopathy was reported by 4% of semaglutide-treated patients vs
The theoretical rationale suggests that sermorelin's growth hormone-stimulating properties might counteract muscle catabolism, though there is no official link established through rigorous clinical trials to support this combination approach
Importantly, the narrative is balanced by acknowledging null findings, such as the study by Shirazi-Beechey et al
TIGER Study Results Source: American Diabetes Association Benefits of Switching to Once-Weekly Semaglutide Patients with T2D who switched to semaglutide, a GLP-1 receptor agonist from Novo Nordisk, from other GLP-1 receptor agonists saw greater A1C reductions and lost more weight after 6 months and were able to maintain those improvements after a year, according to an examination of claims data presented at the ADA Scientific Sessions
Even with good insurance that brings your medication copay down to $100/month, Losing Weight RX still saves around $688 per year